INTEGRA LIFESCIENCES HOLDINGS CORP APIC, Share-based Payment Arrangement, Increase for Cost Recognition
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $5.96 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-07-29
- INTEGRA LIFESCIENCES HOLDINGS CORP apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $5.96M, a 11.59% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $5.04M, a 170.81% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $5.58M, a 27.29% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $5.34M, a 26.89% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $24.44M, a 21.52% increase from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $20.11M, a 27.62% decline from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $27.78M, a 22.80% decline from fiscal 2021.
- INTEGRA LIFESCIENCES HOLDINGS CORP apic, share-based payment arrangement, increase for cost recognition for fiscal 2021 was $35.98M, a 85.47% increase from fiscal 2020.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.96M 10-Q · filed 2026-07-29 | $11.00M derived: sum of 2 quarters · filed 2026-07-29 | ||
| 2026-03-31 | $5.04M 10-Q · filed 2026-07-29 | |||
| 2025-09-30 | $5.58M 10-Q · filed 2025-10-30 | $10.92M derived: sum of 2 quarters · filed 2026-07-29 | $12.78M derived: sum of 3 quarters · filed 2026-07-29 | |
| 2025-06-30 | $5.34M 10-Q · filed 2026-07-29 | $7.20M derived: sum of 2 quarters · filed 2026-07-29 | ||
| 2025-03-31 | $1.86M 10-Q · filed 2026-07-29 | |||
| 2024-12-31 | $24.44M 10-K · filed 2025-02-25 | |||
| 2024-09-30 | $4.39M 10-Q · filed 2025-10-30 | $11.69M derived: sum of 2 quarters · filed 2025-10-30 | $17.30M derived: sum of 3 quarters · filed 2025-10-30 | |
| 2024-06-30 | $7.30M 10-Q · filed 2025-10-30 | $12.92M derived: sum of 2 quarters · filed 2025-10-30 | ||
| 2024-03-31 | $5.61M 10-Q · filed 2025-10-30 | |||
| 2023-12-31 | $20.11M 10-K · filed 2025-02-25 | |||
| 2023-09-30 | $5.46M 10-Q · filed 2024-11-04 | $10.72M derived: sum of 2 quarters · filed 2024-11-04 | $14.34M derived: sum of 3 quarters · filed 2024-11-04 | |
| 2023-06-30 | $5.27M 10-Q · filed 2024-11-04 | $8.88M derived: sum of 2 quarters · filed 2024-11-04 | ||
| 2023-03-31 | $3.61M 10-Q · filed 2024-11-04 | |||
| 2022-12-31 | $27.78M 10-K · filed 2025-02-25 | |||
| 2022-09-30 | $8.95M 10-Q · filed 2023-10-25 | $15.72M derived: sum of 2 quarters · filed 2023-10-25 | $22.04M derived: sum of 3 quarters · filed 2023-10-25 | |
| 2022-06-30 | $6.77M 10-Q · filed 2023-10-25 | $13.09M derived: sum of 2 quarters · filed 2023-10-25 | ||
| 2022-03-31 | $6.32M 10-Q · filed 2023-10-25 | |||
| 2021-12-31 | $35.98M 10-K · filed 2024-02-28 | |||
| 2021-09-30 | $7.75M 10-Q · filed 2022-10-26 | $23.49M derived: sum of 2 quarters · filed 2022-10-26 | $29.59M derived: sum of 3 quarters · filed 2022-10-26 | |
| 2021-06-30 | $15.74M 10-Q · filed 2022-10-26 | $21.84M derived: sum of 2 quarters · filed 2022-10-26 | ||
| 2021-03-31 | $6.10M 10-Q · filed 2022-10-26 | |||
| 2020-12-31 | $19.40M 10-K · filed 2023-02-22 | |||
| 2020-09-30 | $5.41M 10-Q · filed 2021-11-02 | $10.36M derived: sum of 2 quarters · filed 2021-11-02 | $14.14M derived: sum of 3 quarters · filed 2021-11-02 | $19.61M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $4.95M 10-Q · filed 2021-11-02 | $8.73M derived: sum of 2 quarters · filed 2021-11-02 | $14.20M derived: sum of 3 quarters · filed 2022-02-24 | $20.08M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $3.78M 10-Q · filed 2021-11-02 | $9.25M derived: sum of 2 quarters · filed 2022-02-24 | $15.13M derived: sum of 3 quarters · filed 2022-02-24 | $20.93M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $5.47M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $11.35M derived: sum of 2 quarters · filed 2022-02-24 | $17.14M derived: sum of 3 quarters · filed 2022-02-24 | $21.26M 10-K · filed 2022-02-24 |
| 2019-09-30 | $5.87M 10-Q · filed 2020-10-29 | $11.67M derived: sum of 2 quarters · filed 2020-10-29 | $15.79M 10-Q · filed 2019-10-25 | $20.73M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $5.80M 10-Q · filed 2020-10-29 | $9.92M derived: sum of 2 quarters · filed 2020-10-29 | $14.85M derived: sum of 3 quarters · filed 2021-02-23 | $20.41M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $4.12M 10-Q · filed 2020-10-29 | $9.06M derived: sum of 2 quarters · filed 2021-02-23 | $14.62M derived: sum of 3 quarters · filed 2021-02-23 | $20.09M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $4.94M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $10.50M derived: sum of 2 quarters · filed 2021-02-23 | $15.97M derived: sum of 3 quarters · filed 2021-02-23 | $20.71M 10-K · filed 2021-02-23 |
| 2018-09-30 | $5.56M 10-Q · filed 2019-10-25 | $11.03M derived: sum of 2 quarters · filed 2019-10-25 | $15.78M 10-Q · filed 2019-10-25 | |
| 2018-06-30 | $5.47M 10-Q · filed 2019-07-25 | $10.22M derived: sum of 2 quarters · filed 2019-07-25 | ||
| 2018-03-31 | $4.75M 10-Q · filed 2019-07-25 | |||
| 2017-12-31 | $21.90M 10-K · filed 2020-02-21 | |||
| 2017-09-30 | $5.30M 10-Q · filed 2018-11-01 | $11.00M derived: sum of 2 quarters · filed 2018-11-01 | $16.68M derived: sum of 3 quarters · filed 2018-11-01 | |
| 2017-06-30 | $5.70M 10-Q · filed 2018-11-01 | $11.38M derived: sum of 2 quarters · filed 2018-11-01 | ||
| 2017-03-31 | $5.69M 10-Q · filed 2018-11-01 | |||
| 2016-12-31 | $17.31M 10-K · filed 2019-02-26 | |||
| 2015-12-31 | $15.45M 10-K · filed 2018-03-01 | |||
| 2014-12-31 | $14.55M 10-K · filed 2017-02-23 | |||
| 2010-12-31 | $20.77M 10-K · filed 2011-02-24 | |||
| 2009-12-31 | $14.94M 10-K · filed 2011-02-24 | |||
| 2008-12-31 | $32.50M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |